ScreenerHero

VCNXVaccinex, Inc.

NAS · US · Healthcare · Biotechnology · vaccinex.com
1.100USD+10.00%Mkt Cap: 2.94M $P/E: —

Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neurodegenerative diseases, and autoimmune disorders. The company's lead drug …

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap2.94M $
Enterprise Value3.53M $
Revenue (TTM)601.00K $
Gross Profit-11.94M $
Net Income (TTM)-18.63M $
Revenue/Share0.2860 USD
Last Price1.100 USD
Fiscal Year EndDec 2024
MR QuarterDec 2024
Employees23
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-7.86
PEG—
EV/EBITDA-0.19
EV/Revenue5.87
P/S4.90
P/B-0.71
EPS (TTM)-8.88
EPS (Forward)-0.14
52W Range
0.310066% of range1.500
52W High1.500 USD
52W Low0.3100 USD
Profitability
Gross Margin0.00%
Oper. Margin-1590.14%
EBITDA Margin0.00%
Profit Margin-3100.50%
ROE748.95%
ROA-717.80%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-16.19M $
CapEx (TTM)22.00K $
FCF Margin-1920.74%
FCF Yield-392.07%
Net Debt-1.08M $
Net Debt/EBITDA0.06
Balance Sheet
Debt/Equity-0.01
Current Ratio0.50
Quick Ratio0.38
Book Value/Sh-1.5520 USD
Cash/Share0.4140 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:14
Split DateFeb 20, 2024
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.2.68M
Float1.48M
Insiders11.41%
Institutions45.01%
Short Interest
Short Ratio0.6d
Short % Float3.23%
Short % Out.2.32%
Shares Short62.11K
Short (prev mo.)127.50K
Technical
SMA 501.059 (+3.9%)
SMA 2000.9792 (+12.3%)
Beta0.65
S&P 52W Chg18.16%
Avg Vol (30d)786
Avg Vol (10d)2.23K
Technical Indicators
RSI (14)53.9
MACD-0.0171
MACD Signal-0.0153
MACD Hist.-0.0018
BB Upper1.323 USD
BB Middle0.9971 USD
BB Lower0.6711 USD
BB Width65.38%
ATR (14)0.1405 USD
Vol Ratio (20d)11.34x